Para-NO-aspirin inhibits NF-κB and induces apoptosis in B-cell progenitor acute lymphoblastic leukemia

Experimental Hematology

Volumn 40, Issue 3, 2012, Pages

  Khan, Naveed I ^a   Cisterne, Adam ^a   Baraz, Rana ^a   Bradstock, Kenneth F ^b   Bendall, Linda J ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b WESTMEAD HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

2 (ACETYLOXY)BENZOIC ACID 4 (BUTROOXYMETHYL) PHENYL ESTER; ACETYLSALICYLIC ACID; GLUTATHIONE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; NITRIC OXIDE; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG;

ACUTE LYMPHOBLASTIC LEUKEMIA; APOPTOSIS; ARTICLE; CANCER CELL; CELL VIABILITY; CONTROLLED STUDY; DRUG EFFICACY; DRUG POTENCY; ELECTROPHORETIC MOBILITY; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME REGULATION; ENZYME REPRESSION; FLOW CYTOMETRY; HUMAN; HUMAN CELL; PRE B LYMPHOCYTE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TREATMENT RESPONSE; WESTERN BLOTTING;

EID: 84856968549     PISSN: 0301472X     EISSN: 18732399     Source Type: Journal    
DOI: 10.1016/j.exphem.2011.11.001     Document Type: Article

References (33)

1. Nguyen K., Devidas M., Cheng S., et al. Factors influencing survival after relapse from acute lymphoblastic leukemia: a Children's Oncology Group study. Leukemia 2008, 22:2142-2150.
2. Tavernier E., Boiron J., Huguet F., et al. Outcome of treatment after first relapse in adults with acute lymphoblastic leukemia initially treated by the LALA-94 trial. Leukemia 2007, 21:1907-1914.
3. del Soldato P., Sorrentino R., Pinto A. NO-aspirins: a class of new anti-inflammatory and antithrombotic agents. Trends Pharmacol Sci 1999, 20:319-323.
4. Williams J., Borgo S., Hasan I., Castillo E., Traganos F., Rigas B. Nitric oxide-releasing nonsteroidal anti-inflammatory drugs (NSAIDs) alter the kinetics of human colon cancer cell lines more effectively than traditional NSAIDs: implications for colon cancer chemoprevention. Cancer Res 2001, 61:3285-3289.
5. Williams J., Nath N., Chen J., et al. Growth inhibition of human colon cancer cells by nitric oxide (NO)-donating aspirin is associated with cyclooxygenase-2 induction and beta-catenin/T-cell factor signaling, nuclear factor-kappaB, and NO synthase 2 inhibition: implications for chemoprevention. Cancer Res 2003, 63:7613-7618.
6. Khan N.I., Bradstock K.F., Bendall L.J. Activation of Wnt/beta-catenin pathway mediates growth and survival in B-cell progenitor acute lymphoblastic leukaemia. Br J Haematol 2007, 138:338-348.
7. Nygren M., Døsen G., Hystad M., Stubberud H., Funderud S., Rian E. Wnt3A activates canonical Wnt signalling in acute lymphoblastic leukaemia (ALL) cells and inhibits the proliferation of B-ALL cell lines. Br J Haematol 2007, 136:400-413.
8. Kordes U., Krappmann D., Heissmeyer V., Ludwig W., Scheidereit C. Transcription factor NF-kappaB is constitutively activated in acute lymphoblastic leukemia cells. Leukemia 2000, 14:399-402.
9. Miller A., Webb M., Copik A., et al. p38 Mitogen-activated protein kinase (MAPK) is a key mediator in glucocorticoid-induced apoptosis of lymphoid cells: correlation between p38 MAPK activation and site-specific phosphorylation of the human glucocorticoid receptor at serine 211. Mol Endocrinol 2005, 19:1569-1583.
10. McGee M., Greene L., Ledwidge S., et al. Selective induction of apoptosis by the pyrrolo-1,5-benzoxazepine 7-[[dimethylcarbamoyl]oxy]-6-(2-naphthyl)pyrrolo-[2,1-d] (1,5)-benzoxazepine (PBOX-6) in Leukemia cells occurs via the c-Jun NH2-terminal kinase-dependent phosphorylation and inactivation of Bcl-2 and Bcl-XL. J Pharmacol Exp Ther 2004, 310:1084-1895.
11. Crazzolara R., Cisterne A., Thien M., et al. Potentiating effects of RAD001 (Everolimus) on vincristine therapy in childhood acute lymphoblastic leukemia. Blood 2009, 113:3297-3306.
12. Webb C., Bedwell C., Guth A., Avery P., Dow S. Use of flow cytometry and monochlorobimane to quantitate intracellular glutathione concentrations in feline leukocytes. Vet Immunol Immunopathol 2006, 112:129-140.
13. Khan N.I., Cisterne A., Devidas M., et al. Expression of CD44, but not CD44v6, predicts relapse in children with B cell progenitor acute lymphoblastic leukemia lacking adverse or favorable genetics. Leuk Lymphoma 2008, 49:710-718.
14. Bendall L.J., Baraz R., Juarez J., Shen W., Bradstock K.F. Defective p38 mitogen-activated protein kinase signaling impairs chemotaxic but not proliferative responses to stromal-derived factor-1alpha in acute lymphoblastic leukemia. Cancer Res 2005, 65:3290-3298.
15. Gao J., Liu X., Rigas B. Nitric oxide-donating aspirin induces apoptosis in human colon cancer cells through induction of oxidative stress. Proc Natl Acad Sci U S A 2005, 102:17207-17212.
16. Razavi R., Gehrke I., Gandhirajan R.K., Poll-Wolbeck S.J., Hallek M., Kreuzer K.A. Nitric oxide-donating acetylsalicylic acid induces apoptosis in chronic lymphocytic leukemia cells and shows strong antitumor efficacy invivo. Clin Cancer Res 2011, 17:286-293.
17. Kamata H., Honda S., Maeda S., Chang L., Hirata H., Karin M. Reactive oxygen species promote TNFalpha-induced death and sustained JNK activation by inhibiting MAP kinase phosphatases. Cell 2005, 120:649-661.
18. Hundley T., Rigas B. Nitric oxide-donating aspirin inhibits colon cancer cell growth via mitogen-activated protein kinase activation. J Pharmacol Exp Ther 2006, 316:25-34.
19. Nath N., Kashfi K., Chen J., Rigas B. Nitric oxide-donating aspirin inhibits beta-catenin/T cell factor (TCF) signaling in SW480 colon cancer cells by disrupting the nuclear beta-catenin-TCF association. Proc Natl Acad Sci U S A 2003, 100:12584-12589.
20. Braun T., Carvalho G., Fabre C., Grosjean J., Fenaux P., Kroemer G. Targeting NF-kappaB in hematologic malignancies. Cell Death Differ 2006, 13:748-758.
21. Schreck R., Rieber P., Baeuerle P.A. Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-kappa B transcription factor and HIV-1. EMBO J 1991, 10:2247-2258.
22. Sahai E., Olson M., Marshall C. Cross-talk between Ras and Rho signalling pathways in transformation favours proliferation and increased motility. EMBO J 2001, 20:755-766.
23. Rodriguez P., Sahay S., Olabisi O., Whitehead I. ROCK I-mediated activation of NF-kappaB by RhoB. Cell Signal 2007, 19:2361-2369.
24. Anwar K.N., Fazal F., Malik A.B., Rahman A. RhoA/Rho-associated kinase pathway selectively regulates thrombin-induced intercellular adhesion molecule-1 expression in endothelial cells via activation of I kappa B kinase beta and phosphorylation of RelA/p65. J Immunol 2004, 173:6965-6972.
25. Ginn-Pease M., Whisler R. Optimal NF kappa B mediated transcriptional responses in Jurkat T cells exposed to oxidative stress are dependent on intracellular glutathione and costimulatory signals. Biochem Biophys Res Commun 1996, 226:695-702.
26. Meng X., Martinez M.A., Raymond-Stintz M.A., Winter S.S., Wilson B.S. IKK inhibitor bay 11-7082 induces necroptotic cell death in precursor-B acute lymphoblastic leukaemic blasts. Br J Haematol 2010, 148:487-490.
27. Nath N., Labaze G., Rigas B., Kashfi K. NO-donating aspirin inhibits the growth of leukemic Jurkat cells and modulates beta-catenin expression. Biochem Biophys Res Commun 2005, 326:93-99.
28. Rigas B., Williams J. NO-donating NSAIDs and cancer: an overview with a note on whether NO is required for their action. Nitric Oxide 2008, 19:199-204.
29. McCubrey J., Lahair M., Franklin R. Reactive oxygen species-induced activation of the MAP kinase signaling pathways. Antioxid Redox Signal 2006, 8:1775-1789.
30. Tikoo K., Lau S., Monks T. Histone H3 phosphorylation is coupled to poly-(ADP-ribosylation) during reactive oxygen species-induced cell death in renal proximal tubular epithelial cells. Mol Pharmacol 2001, 60:394-402.
31. Munzert G., Kirchner D., Ottmann O., Bergmann L., Schmid R. Constitutive NF-kappab/Rel activation in philadelphia chromosome positive (Ph+) acute lymphoblastic leukemia (ALL). Leuk Lymphoma 2004, 45:1181-1184.
32. Matsumaru K., Ji C., Kaplowitz N. Mechanisms for sensitization to TNF-induced apoptosis by acute glutathione depletion in murine hepatocytes. Hepatology 2003, 37:1425-1434.
33. Williams J., Ji P., Ouyang N., Liu X., Rigas B. NO-donating aspirin inhibits the activation of NF-kappaB in human cancer cell lines and Min mice. Carcinogenesis 2008, 29:390-397.